NCT05523427View on ClinicalTrials.gov

Probiotics as Adjuvant Therapy in the Management of Irritable Bowel Syndrome

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

December 21, 2022

Study Completion Date

January 6, 2023

Conditions
Irritable Bowel SyndromeIrritable Bowel Syndrome With Diarrhea
Interventions
DIETARY_SUPPLEMENT

Two probiotic strains (L. plantarum and L. acidophilus)

A capsule containing the L. plantarum and L. acidophilus strains is to be administered twice daily for three months in addition to the standard treatment of IBS.

Trial Locations (1)

41001

University of Mosul, Mosul

All Listed Sponsors
lead

University of Mosul

OTHER